← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Roger Williams Medical Center
Providence, RI
$8,661,821
Total funding
6
Grants
Funding over time
peak $5.9M · FY2009–18$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
DOD$5,910,691 · 1
NIH$2,751,130 · 5
By mechanism
—$5,910,691 · 1
R01$2,305,798 · 3
K08$335,332 · 1
R03$110,000 · 1
Investigators at Roger Williams Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
T-CELL GENE THERAPY TO ERADICATE DISSEMINATED BREAST CANCERS$5,910,691
· FY2009 · Department of Defense
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$425,750
R01 · FY2016 · HL
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$425,750
R01 · FY2017 · HL
p38 acetylation: Novel signaling mechanisms and myocardial protection$422,627
R01 · FY2015 · HL
p38 acetylation: Novel signaling mechanisms and myocardial protection$414,086
R01 · FY2016 · HL
A Bioengineering Approach to Create Immunorejection Free Human Pancreatic Islets$370,403
R01 · FY2015 · DK
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$192,686
R01 · FY2018 · HL
Reversing genetically modified T cell suppression in a model of liver metastases$167,666
K08 · FY2015 · CA
Reversing genetically modified T cell suppression in a model of liver metastases$167,666
K08 · FY2016 · CA
In-vitro model to recapitulate the natural HIV-1 latency$55,000
R03 · FY2016 · AI
In-vitro model to recapitulate the natural HIV-1 latency$55,000
R03 · FY2015 · AI
A Bioengineering Approach to Create Immunorejection Free Human Pancreatic Islets$54,496
R01 · FY2015 · DK